$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Peptides and compounds that bind to the IL-1 receptor 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-038/08
  • A61K-038/00
  • C07K-007/04
출원번호 US-0465391 (1995-06-05)
발명자 / 주소
  • Barrett Ronald W.
  • Yanofsky Stephen D.
  • Baldwin David
  • Jacobs Jeff W.
  • Bovy Phillipe R.
  • Leahy Ellen M.
  • Pottorf Richard S.
출원인 / 주소
  • Hoechst Marion Roussel, Inc.
대리인 / 주소
    Murphy
인용정보 피인용 횟수 : 51  인용 특허 : 0

초록

Peptides that bind to the interleukin-1 type I receptor (IL-1RtI) can be used to assay the amount of IL-1R, or an IL-1R agonist or antagonist, in a sample and comprise a sequence of amino acids selected from the group consisting of (1) WXXXGZ.sub.1 W where Z.sub.1 is L, I, A, or Q; (2) XXQZ.sub.5 YZ

대표청구항

[ We claim:] [1.] A method of antagonizing action of Interleukin-1 on an interleukin-1 type I receptor, the method comprising contacting the receptor with a compound that binds to an interleukin-1 type I receptor having from about 11 to 40 amino acids in length and a core sequence of amino selected

이 특허를 인용한 특허 (51)

  1. Smith, Craig A.; Wiley, Steven; Kaykas, Ajamete; Probst, Peter, CD47 related compositions and methods for treating immunological diseases and disorders.
  2. Zamora, Paul O.; Atkinson, Brent Lee; Lin, Xinhua; Pena, Louis A., Composition and method for delivery of BMP-2 amplifier/co-activator for enhancement of osteogenesis.
  3. Zamora, Paul O.; Atkinson, Brent Lee; Lin, Xinhua; Pena, Louis A., Composition and method for delivery of BMP-2 amplifier/co-activator for enhancement of osteogenesis.
  4. Zamora, Paul; Atkinson, Brent Lee; Lin, Xinhua; Pena, Louis A., Composition and method for delivery of BMP-2 amplifier/co-activator for enhancement of osteogenesis.
  5. Zamora, Paul; Atkinson, Brent Lee; Lin, Xinhua; Pena, Louis A., Composition and method for delivery of BMP-2 amplifier/co-activator for enhancement of osteogenesis.
  6. Zamora, Paul O.; Atkinson, Brent Lee, Composition comprising BMP-2 amplifier/co-activator for enhancement of osteogenesis.
  7. Anderson, Norman G.; Anderson, N. Leigh; Braatz, James A., Dry deposition of materials for microarrays using matrix displacement.
  8. Zamora, Paul O.; Pena, Louis A.; Lin, Xinhua, Dual chain synthetic heparin-binding growth factor analogs.
  9. Zamora, Paul O.; Pena, Louis A.; Lin, Xinhua, Dual chain synthetic heparin-binding growth factor analogs.
  10. Zamora, Paul O.; Pena, Louis A.; Lin, Xinhua; Takahashi, Kazuyuki, FGF growth factor analogs.
  11. Zamora, Paul O.; Campion, Sarah, Formulations and methods for delivery of growth factor analogs.
  12. Zamora,Paul O.; Pena,Louis A.; Lin,Xinhua, Growth factor analogs.
  13. Pena, Louis A.; Zamora, Paul O.; Lin, Xinhua; Takahashi, Kazuyuki, Heterodimeric chain synthetic heparin-binding growth factor analogs.
  14. Heavner, George A.; Knight, David M.; Ghrayeb, John; Scallon, Bernard J.; Nesspor, Thomas C.; Huang, Chichi, Human EPO mimetic hinge core mimetibodies, compositions, methods and uses.
  15. Beutler,Bruce A.; Poltorak,Alexander, LPS-response gene compositions and methods.
  16. Zamora, Paul O.; Takahashi, Kazuyuki; Lin, Xinhua, Laminin-derived multi-domain peptides.
  17. Callahan, William J.; Remmele, Jr., Richard L.; Ratnaswamy, Gayathri; Latypov, Ramil F.; Liu, Dingjiang, Lyophilized therapeutic peptibody formulations.
  18. Callahan, William J.; Remmele, Jr., Richard L.; Ratnaswamy, Gayathri; Latypov, Ramil F.; Liu, Dingjiang, Lyophilized therapeutic peptibody formulations.
  19. Wiley, Steven; Smith, Craig A; Kaykas, Ajamete, Methods for identifying polypeptide targets and uses thereof for treating immunological diseases.
  20. Anderson, Norman G.; Anderson, N. Leigh, Microarrays and their manufacture.
  21. Anderson, Norman G.; Anderson, N. Leigh, Microarrays and their manufacture.
  22. Anderson, Norman G.; Anderson, N. Leigh; Braatz, James A., Microarrays and their manufacture.
  23. Anderson,N. Leigh; Anderson,Norman G.; Braatz,James A., Microarrays and their manufacture by slicing.
  24. Gegg, Colin V.; Walker, Kenneth W.; Miranda, Leslie P.; Xiong, Fei, Modified Fc molecules.
  25. Gegg, Colin V.; Walker, Kenneth W.; Miranda, Leslie P.; Xiong, Fei, Modified Fc molecules.
  26. Gegg, Colin V.; Walker, Kenneth W.; Miranda, Leslie P.; Xiong, Fei, Modified Fc molecules.
  27. Gegg, Colin; Xiong, Fei; Sitney, Karen C., Modified Fc molecules.
  28. Gegg, Colin; Xiong, Fei; Sitney, Karen C., Modified Fc molecules.
  29. Gegg, Colin; Xiong, Fei; Sitney, Karen C., Modified Fc molecules.
  30. Gegg, Colin; Xiong, Fei; Sitney, Karen C., Modified Fc molecules.
  31. Gegg, Colin; Xiong, Fei; Sitney, Karen C., Modified Fc molecules.
  32. Gegg, Colin; Xiong, Fei; Sitney, Karen C., Modified Fc molecules.
  33. Gegg,Colin; Xiong,Fei; Sitney,Karen C., Modified Fc molecules.
  34. Feige, Ulrich; Liu, Chuan-Fa, Modified peptides as therapeutic agents.
  35. Feige,Ulrich, Modified peptides as therapeutic agents.
  36. Feige,Ulrich, Modified peptides as therapeutic agents.
  37. Feige,Ulrich, Modified peptides as therapeutic agents.
  38. Feige,Ulrich, Modified peptides as therapeutic agents.
  39. Feige,Ulrich; Liu,Chuan Fa; Cheetham,Janet C.; Boone,Thomas Charles; Gudas,Jean Marie, Modified peptides as therapeutic agents.
  40. Zamora, Paul O.; Pena, Louis A.; Lin, Xinhua; Kazuyuki, Takahashi, Positive modulator of bone morphogenic protein-2.
  41. Zamora,Paul O.; Pena,Louis A.; Lin,Xinhua; Takahashi,Kazuyuki, Positive modulator of bone morphogenic protein-2.
  42. Takahashi, Kazuyuki; Zamora, Paul O.; Pena, Louis A.; Lin, Xinhua, Single branch heparin-binding growth factor analogs.
  43. Pena, Louis A.; Zamora, Paul O.; Lin, Xinhua; Glass, John D., Synthetic heparin-binding factor analogs.
  44. Pe?a,Louis A.; Zamora,Paul; Lin,Xinhua; Glass,John D., Synthetic heparin-binding growth factor analogs.
  45. Walker, Kenneth W.; Kinstler, Olaf B.; Sitney, Karen C., Therapeutic peptides.
  46. Liu, Chuan-Fa; Feige, Ulrich; Cheetham, Janet C., Thrombopoietic compounds.
  47. Liu, Chuan-Fa; Feige, Ulrich; Cheetham, Janet C., Thrombopoietic compounds.
  48. Liu, Chuan-Fa; Feige, Ulrich; Cheetham, Janet C., Thrombopoietic compounds.
  49. Liu, Chuan-Fa; Feige, Ulrich; Cheetham, Janet C., Thrombopoietic compounds.
  50. Liu, Chuan-Fa; Feige, Ulrich; Cheetham, Janet C., Thrombopoietic compounds.
  51. Liu, Chuan-Fa; Feige, Ulrich; Cheetham, Janet C., Thrombopoietic compounds.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로